This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Siemens Healthcare Launches CareXcell™ For Sustainable Population Health Management

Today, Siemens Healthcare announced the launch of CareXcell, the latest addition to the company’s portfolio of next-generation IT solutions designed to help healthcare providers successfully address the new care and payment requirements of value-based and accountable care models. CareXcell comprises innovative technologies that help facilitate improved care management and risk stratification of individual patients and entire populations through open communication and data sharing across providers, care venues, and transitions. Evidence-based care plans, integrated with underlying business process management technology, support the delivery of high-quality, cost-effective care across the continuum to help improve outcomes and increase patient and provider satisfaction. Siemens Healthcare is also announcing that Inspira Health Network is the first provider to sign up for the CareXcell cloud-based service.

“The successful transition to value-based purchasing models requires new strategies and tools that shift population health management from reactive to proactive throughout the entire lifecycle of care,” said John Glaser, PhD, CEO, Health Services, Siemens Healthcare. “CareXcell provides a collaborative framework for improving care delivery and monitoring across a community, integrating advanced workflow and event-processing technology with clinical evidence to help providers address patients’ health and risk factors in a timelier, more efficient manner.”

CareXcell consolidates and normalizes patient data from disparate EHRs and clinical systems into a single patient-centered repository through any health information exchange. Accessing summarized, real-time clinical data improves provider efficiency in identifying and addressing patient-specific issues and risk factors before they become more severe, costly conditions. For example, CareXcell can help providers initiate appropriate interventions as part of patients’ personalized care plans to help improve long-term outcomes, keeping rising-risk patients from becoming high-risk, high-cost utilizers and ultimately strengthening their bottom line.

Evidence-based care plans drive CareXcell’s patient-specific interventions for chronic conditions, risk reduction, and prevention. The care plans are supplied by Motive Medical Intelligence, a leader in providing actionable, evidence-based intelligence inside clinical workflow and point-of-care solutions. Motive’s dynamic care plans, integrated within the embedded business process management technology, deliver patient-specific messages for evidence-based interventions at every point in the care workflow. An underlying workflow engine monitors the care plan activities for completion or deviations, triggering timely patient-specific interventions and event-based alerts, as well as escalating missed tasks to a specified care team member. CareXcell simplifies workflow across the care team by giving providers real-time decision support, identifying care gaps, recommending actionable interventions triggered by those gaps, and documenting problems and goals.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs